FORA Forian Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$2.17

Period return

+0.02 (+0.93%)

Volume

2026-05-15O $2.17 H $2.17 L $2.17 C $2.17MA5 $2.17MA20 $2.16MA60 $2.11

6M · 110 barsYahoo Finance · USD2025-12-08 → 2026-05-15

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2024. 11. 15.LowBUY2 years ago
Roth MKM: Buy
US analyst rating / recommendation change.
2024. 04. 04.LowBUY2 years ago
Roth MKM: Buy
US analyst rating / recommendation change.
2023. 12. 20.MediumBUY2 years ago
Roth MKM: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc. operates as a subsidiary of 2025 Acquisition Company, LLC.

Sector: Healthcare
Industry: Health Information Services
HQ: Newtown, PA, United States
Fiscal year end: —
Employees: 50
IPO date: —

View details →

2023. 08. 12.LowBUY3 years ago

Lake Street: Buy

US analyst rating / recommendation change.

2022. 11. 10.LowBUY4 years ago

RBC Capital: Outperform

US analyst rating / recommendation change.

2022. 04. 08.MediumBUY4 years ago

Lake Street: Buy

US analyst rating / recommendation change.

Stored first · Google News · Yahoo Finance (English)

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 12.	After market close (AMC)	—	—	—	—	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-0.04	—	—	$7.06M	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$-0.13	—	—	$14.34M	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.12	—	—	$9.65M	Reported

Date	Firm	Analyst	Action	Rating change	Price target	Report
2024. 11. 15.	Roth MKM	—	Maintain	Buy → Buy	—	Roth MKM: Buy
2024. 04. 04.	Roth MKM	—	Maintain	Buy → Buy	—	Roth MKM: Buy
2023. 12. 20.	Roth MKM	—	Initiate coverage	— → Buy	—	Roth MKM: Buy
2023. 08. 12.	Lake Street	—	Maintain	Buy → Buy	—	Lake Street: Buy
2022. 11. 10.	RBC Capital	—	Maintain	— → Outperform	—	RBC Capital: Outperform
2022. 04. 08.	Lake Street	—	Initiate coverage	— → Buy	—	Lake Street: Buy

Key stats

As of FY2026Q1 · Source: SEC/DART + price data

Market cap$67.79M

Shares out.31M

PER—

EPS (TTM)-$0.33

PBR2.26x

BPS$0.96

Dividend/share—

Dividend yield—

No holdings data to show.

Top news